newsfilter
← Latest News
FDA Approved Drugs·

Approval of Sandimmune, Nda #050573 (Labeling)

Approval Date: 03/06/2026; Drug Name: Sandimmune, Nda #050573; Active Ingredients: CYCLOSPORINE; Company: Novartis; Submission Status: Approval; Submission Classification: Labeling; Application Number: 050573

Company
NOVARTIS
Keywords
NOVARTIS